Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05508906
Title Phase 1b Combo w/ Ribociclib and Alpelisib
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Olema Pharmaceuticals, Inc.
Age Groups: adult | senior
Covered Countries USA | AUS

No variant requirements are available.